Location History:
- Tainan 701, TW (2010)
- Tainan, TW (1988 - 2019)
- Taipei, TW (2022)
Company Filing History:
6 out of 6 
1 out of 2,119 
1 out of 544 Years Active: 1988-2022
Title: Innovations and Contributions of Inventor Hua-Lin Wu
Introduction
Hua-Lin Wu is a prominent inventor based in Tainan, Taiwan. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents for eye diseases. With a total of 16 patents to his name, Wu's work has the potential to impact the treatment of various ocular conditions.
Latest Patents
One of Wu's latest patents focuses on the use of recombinant thrombomodulin domain 1 (TMD1) for treating eye diseases associated with pathological ocular angiogenesis. This application highlights the dual anti-angiogenic and anti-inflammatory effects of TMD1. The invention discloses an isolated recombinant polypeptide that is at least 80% identical to TMD1, intended for treating eye disorders such as retinopathy of prematurity, diabetic retinopathy, and age-related macular degeneration. Another significant patent involves a pharmaceutical composition designed to promote wound healing and accelerate the closure of open wounds. This composition includes a therapeutically effective amount of a recombinant polypeptide that is at least 80% identical to a specific amino acid sequence.
Career Highlights
Throughout his career, Hua-Lin Wu has worked with various organizations, including Blue Blood Biotech Corporation. His innovative research has led to advancements in therapeutic applications, particularly in the realm of ocular health.
Collaborations
Wu has collaborated with notable colleagues such as Guey-Yueh Shi and Chih-Yuan Ma. These partnerships have contributed to the development of his groundbreaking inventions and patents.
Conclusion
Hua-Lin Wu's contributions to the field of biomedical research, particularly in treating eye diseases, showcase his innovative spirit and dedication to improving patient outcomes. His patents reflect a commitment to advancing medical science and enhancing therapeutic options for those in need.